Role of Surface Active Agents in Transferosome for Systemic Drug Delivery

Authors

  • Mohsin Hussein Abdulameer Department of Pharmaceutics, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
  • Nidhal K. Maraie Department of Pharmaceutics, College of Pharmacy, Al Farahidi University, Baghdad, Iraq
  • Zainab H. Mahdi Department of Pharmaceutical Sciences and Pharmaceutics, Applied Science Private University, Amman, Jordan

DOI:

https://doi.org/10.32947/ajps.v25i1.1107

Keywords:

lipid based vesicles, surface active agent, surfactant, transferosome

Abstract

The recent utilization of transferosomes (a type of vesicular drug-carrier system) has shown promising results in enhancing the transport of drugs through the skin when administered topically. Phospholipids and surface active agents constitute the primary components of these entities. Surface active agents play a crucial role in enhancing the permeability and flexibility of lipid bilayers.

The present research critically examines previous studies to gain insights into the influence of surface active agents on the characteristics and performance of transferosomes. Specifically, it focuses on the effects of these agents on transferosome size, entrapment efficiency (EE), zeta potential, stability, and transdermal flux. The type of surface active agent generally exerts a notable influence on the size of vesicles, encapsulation efficiency (EE), and zeta potential. This phenomenon could potentially be attributed to variations in the hydrophilic-lipophilic balance (HLB), the hydrophilicity of the surface active agent, and the length of the carbon chain. Therefore, it is imperative to investigate the influence of surface active agent properties in the development of transferosomes. The evaluation of the cytocompatibility of surface active compounds was also incorporated into the study.

References

1- Mohammed MM, Hamadi SA, Aljaf AN. Formulation of melatonin as a cream and studying the release, diffusion, and stability of the cream. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2009;6(1):43-55.

2- Akram MW, Jamshaid H, Rehman FU, Zaeem M, Khan Jz, Zeb A. Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery. AAPS PharmSciTech. 2022; 23:1-18.

3- Rajan R, Jose S, Mukund VB, Vasudevan DT. Transferosomes-A vesicular transdermal delivery system for enhanced drug permeation. Journal of advanced pharmaceutical Technology & Research. 2011;2(3):138-43.

4- Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. International journal of pharmaceutics. 2020; 573:118-817.

5- Chaurasiya P, Ganju E, Upmanyu N, Ray SK, Jain P. Transfersomes: a novel technique for transdermal drug delivery. Journal of drug delivery and therapeutics. 2019;9(1):27-985.

6- Ghosh S, Ray A, Pramanik N. Self-assembly of surfactants: An overview on general aspects of amphiphiles. Biophysical Chemistry. 2020; 265:106-429.

7- Holmberg K, Jönsson B, Kronberg B, Lindman B. Polymers in solution. Surfactants and polymers in aqueous solution John Wiley & Sons, Ltd. 2003:193-214.

8- Perger T-M, Bešter-Rogač M. Thermodynamics of micelle formation of alkyltrimethylammonium chlorides from high performance electric conductivity measurements. Journal of colloid and interface science. 2007;313(1):288-95.

9- Tsubone K, Rosen MJ. Structural effect on surface activities of anionic surfactants having N-acyl-N-methylamide and carboxylate groups. Journal of colloid and interface science. 2001;244(2):394-8.

10- Summerton E, Zimbitas G, Britton M, Bakalis S. Low temperature stability of surfactant systems. Trends in Food Science & Technology. 2017; 60:23-30.

11- Hegazy M, El-Tabei A. Fundamental and Application of Surface Active Agents in Petroleum Industry as Corrosion Inhibitors. Surfactants in Upstream E&P: Springer; 2021. p. 383-99.

12- Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences. 2012;4(1):2.

13- Tadros TF. Applied surfactants: principles and applications: John Wiley & Sons; 2006.

14- Cortés H, Hernández-Parra H, Bernal-Chávez SA, Prado-Audelo MLD, Caballero-Florán IH, Borbolla-Jiménez FV, et al. Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses. Materials. 2021;14(12):31-97.

15- Manfredini N, Gardoni G, Sponchioni M, Moscatelli D. Thermo-Responsive Polymers as Surface Active Compounds: A Review. European Polymer Journal. 2023:112-421.

16- Raffa P, Wever DAZ, Picchioni F, Broekhuis AA. Polymeric surfactants: synthesis, properties, and links to applications. Chemical reviews. 2015;115(16):850-463.

17- Lutz JF. Solution self‐assembly of tailor‐made macromolecular building blocks prepared by controlled radical polymerization techniques. Polymer international. 2006;55(9):97-993.

18- 18. Griffin WC. Classification of surface-active agents by" HLB". J Soc Cosmet Chem. 1949;1:311-26.

19- Pillai P, Mandal A. Synthesis and characterization of surface-active ionic liquids for their potential application in enhanced oil recovery. Journal of Molecular Liquids. 2022; 345:117-900.

20- Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. International journal of pharmaceutics. 2002;241(2):319-27.

21- Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta pharmaceutica sinica B. 2011;1(4):208-19.

22- Bnyan R, Khan I, Ehtezazi T, Saleem I, Gordon S, O'Neill F, et al. Surfactant effects on lipid-based vesicles properties. Journal of pharmaceutical sciences. 2018;107(5):1237-46.

23- Wu P-S, Li Y-S, Kuo Y-C, Tsai S-JJ, Lin C-C. Preparation and evaluation of novel transfersomes combined with the natural antioxidant resveratrol. Molecules. 2019;24(3):600.

24- Balata GF, Faisal MM, Elghamry HA, Sabry SA. Preparation and characterization of ivabradine HCl transfersomes for enhanced transdermal delivery. Journal of drug delivery science and technology. 2020;60:101-921.

25- Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interaction. European Journal of Pharmaceutics and Biopharmaceutics. 2011;78(1):27-35.

26- Shaji J, Lal M. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int J Pharm Pharm Sci. 2014;6(1):467-77.

27- Barbosa R, Severino P, Preté P, Santana M. Influence of different surfactants on the physicochemical properties of elastic liposomes. Pharmaceutical development and technology. 2017;22(3):360-9.

28- Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Advanced biomedical research. 2016;5.

29- Das B, Sen SO, Maji R, Nayak AK, Sen KK. Transferosomal gel for transdermal delivery of risperidone: Formulation optimization and ex vivo permeation. Journal of Drug Delivery Science and Technology. 2017; 38:59-71.

30- Basha M, Abd El-Alim SH, Shamma RN, Awad GE. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. Journal of liposome research. 2013;23(3):203-10.

31- Hadi HA, Hussein AH. Effect of Addition a Sodium Deoxycholate as an Edge Activator-for Preparation of Ondansetron HCl Tansfersomal Dispersion. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2023;23(4):429-42.

32- van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. International journal of pharmaceutics. 2001;217(1-2):13-24.

33- El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. International journal of pharmaceutics. 2010;397(1-2):164-72.

34- Mahmood S, Chatterjee B, Mandal UK. Pharmacokinetic evaluation of the synergistic effect of raloxifene loaded transfersomes for transdermal delivery. Journal of Drug Delivery Science and Technology. 2021;63:102-545.

35- Simões S, Tapadas J, Marques C, Cruz M, Martins M, Cevc G. Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. European journal of pharmaceutical sciences. 2005;26(3-4):307-17.

36- Gupta A, Aggarwal G, Singla S, Arora R. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation. Scientia pharmaceutica. 2012;80(4):1061-80.

37- Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Nanosized transferosome-based intranasal in situ gel for brain targeting of resveratrol: formulation, optimization, in vitro evaluation, and in vivo pharmacokinetic study. Aaps pharmscitech. 2019;20(5):1-14.

38- Shuwaili AHA, Rasool BKA, Abdulrasool AA. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. European journal of pharmaceutics and biopharmaceutics. 2016; 102:101-14.

39- Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi pharmaceutical journal. 2012;20(4):355-63.

40- Schuh RS, Bruxel F, Teixeira HF. Physicochemical properties of lecithin-based nanoemulsions obtained by spontaneous emulsification or high-pressure homogenization. Química Nova. 2014; 37:1193-8.

41- El Sayyad M, Zaky A, Samy A. Fabrication and characterization of sildenafil citrate loaded transfersomes as a carrier for transdermal drug delivery. Pharm Pharmacol Int J. 2017; 5:37-46.

42- Mahmood S, Chatterjee B, Mandal U. Nano transfersomes vesicles of raloxifene hcl with sorbitan 80: Formulation and characterization. Bioequiv Bioavailab Int J. 2018;2:1-7.

43- Yang X, Lu G, Huang K, Wang R, Duan X, Yang C, et al. Synergistic solubilization of low-brominated diphenyl ether mixtures in nonionic surfactant micelles. Journal of Molecular Liquids. 2016; 223:252-60.

44- Abdelmonem R, Hamed RR, Abdelhalim SA, ElMiligi MF, El-Nabarawi MA. Formulation and characterization of cinnarizine targeted aural transfersomal gel for vertigo treatment: a pharmacokinetic study on rabbits. International Journal of Nanomedicine. 2020; 15:62-11.

45- Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochimica et biophysica acta (BBA)-biomembranes. 2001;1514(2):191-205.

46- Uwaezuoke O, Du Toit LC, Kumar P, Ally N, Choonara YE. Linoleic Acid-Based Transferosomes for Topical Ocular Delivery of Cyclosporine A. Pharmaceutics. 2022;14(8):16-95.

47- Sassine J, Sousa J, Lalk M, Daniel RA, Vollmer W. Cell morphology maintenance in Bacillus subtilis through balanced peptidoglycan synthesis and hydrolysis. Scientific reports. 2020;10(1):1-14.

48- Lee EH, Kim A, Oh Y-K, Kim C-K. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials. 2005;26(2):205-10.

Downloads

Published

2025-01-14

How to Cite

Role of Surface Active Agents in Transferosome for Systemic Drug Delivery. (2025). Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(1), 68-80. https://doi.org/10.32947/ajps.v25i1.1107

Similar Articles

1-10 of 190

You may also start an advanced similarity search for this article.